Search Results - "Marzouka, George R"

Extracellular Vesicles as Delivery Systems in Disease Therapy by Picon, Manuel Alejandro, Wang, Liyong, Da Fonseca Ferreira, Andrea, Dong, Chunming, Marzouka, George R

“…Extracellular vesicles (EVs)/exosomes are nanosized membrane-bound structures that are released by virtually all cells. EVs have attracted great attention in…”
Get full text

The association between in-hospital hemoglobin changes, cardiovascular events, and mortality in acute decompensated heart failure: Results from the ESCAPE trial by Damluji, Abdulla A, Macon, Conrad, Fox, Arieh, Garcia, Grettel, Al-Damluji, Mohammed S, Marzouka, George R, Myerburg, Robert J, Gilchrist, Ian C, Cohen, Mauricio G, Moscucci, Mauro

“…Abstract Introduction The effect of acute changes of hemoglobin during index heart failure admission on long-term outcomes remains unknown. Methods We examined…”
Get full text

Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial) by Badheka, Apurva O., MD, Patel, Nileshkumar J., MD, Grover, Peeyush M., MD, Shah, Neeraj, MD, Patel, Nilay, MD, Singh, Vikas, MD, Deshmukh, Abhishek J., MD, Mehta, Kathan, MD, Chothani, Ankit, MD, Savani, Ghanshyambhai T., MD, Arora, Shilpkumar, MD, Rathod, Ankit, MD, Marzouka, George R., MD, Lafferty, James, MD, Mehta, Jawahar L., MD, Mitrani, Raul D., MD

“…Many medications used to treat atrial fibrillation (AF) also reduce blood pressure (BP). The relation between BP and mortality is unclear in patients with AF…”
Get full text

Acute Coronary Syndrome During the Era of COVID-19: Perspective and Implications Using Google Trends by Quintero-Martinez, Juan A., Espinoza, Joaquin, Celli, Diego, Vergara-Sanchez, Carlos, Salter, Jonathan, Aitken, William, Palacios, Igor, Cohen, Mauricio G., Rengifo-Moreno, Pablo, de Marchena, Eduardo, Colombo, Rosario, Alfonso, Carlos E., Marzouka, George R.

“…Acute coronary syndrome (ACS) hospital admissions decreased during the start of the COVID-19 outbreak. Information is limited on how Google searches were…”
Get full text

New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial by Damluji, Abdulla A., MD, MPH, Al-Damluji, Mohammed S., MD, MPH, Marzouka, George R., MD, Coffey, James O., MD, Viles-Gonzalez, Juan F., MD, PhD, Cohen, Mauricio G., MD, Moscucci, Mauro, MD, MBA, Myerburg, Robert J., MD, Mitrani, Raul D., MD

“…Background There are limited data on prognosis and outcomes of patients with new-onset atrial fibrillation (AF) compared with those with a prior history of AF…”
Get full text

Isolated Nonspecific ST-Segment and T-Wave Abnormalities in a Cross-Sectional United States Population and Mortality (from NHANES III) by Badheka, Apurva O., MD, Rathod, Ankit, MD, Marzouka, George R., MD, Patel, Nileshkumar, MD, Bokhari, Syed S.I., MD, Moscucci, Mauro, MD, Cohen, Mauricio G., MD

“…Most clinicians regard isolated, minor, or nonspecific ST-segment and T-wave (NS-STT) abnormalities to be incidental, often transient, and benign findings in…”
Get full text

ST-T Wave Abnormality in Lead aVR and Reclassification of Cardiovascular Risk (from the National Health and Nutrition Examination Survey-III) by Badheka, Apurva O., MD, Patel, Nileshkumar J., MD, Grover, Peeyush M., MD, Shah, Neeraj, MD, Singh, Vikas, MD, Deshmukh, Abhishek, MD, Mehta, Kathan, MD, Chothani, Ankit, MD, Hoosien, Michael, MD, Rathod, Ankit, MD, Savani, Ghanshyambhai T., MD, Marzouka, George R., MD, Gupta, Sandeep, MD, Mitrani, Raul D., MD, Moscucci, Mauro, MD, Cohen, Mauricio G., MD

“…Electrocardiographic lead aVR is often ignored in clinical practice. The aim of this study was to investigate whether ST-T wave amplitude in lead aVR predicts…”
Get full text

Combined Use of Impella Left Ventricular Assist Device and Extracorporeal Membrane Oxygenation as a Bridge to Recovery in Fulminant Myocarditis by Chaparro, Sandra V, Badheka, Apurva, Marzouka, George R, Tanawuttiwat, Tanyanan, Ahmed, Fayaz, Sacher, Vikas, Pham, Si M

“…Myocarditis may result in cardiogenic shock, and when medical therapy is unable to maintain adequate cardiac output, mechanical circulatory support is…”
Get full text

Electrocardiographic Abnormalities and Reclassification of Cardiovascular Risk: Insights from NHANES-III by Badheka, Apurva O., MD, Patel, Nileshkumar, MD, Tuliani, Tushar A., MD, Rathod, Ankit, MD, Marzouka, George R., MD, Zalawadiya, Sandip, MD, Deshmukh, Abhishek, MD, Moscucci, Mauro, MD, Cohen, Mauricio G., MD

“…Abstract Background We aimed to assess the additive value of electrocardiogram (ECG) findings to risk prediction models for cardiovascular disease. Methods Our…”
Get full text

The CHA2DS2-VASc Score for Risk Stratification of Stroke in Heart Failure With-vs-Without Atrial Fibrillation by Marzouka, George R., Rivner, Harold, Mehta, Vijay, Lopez, Juan, Vaz, Igor, Tang, Fei, Ishwaran, Hemant, Goldberger, Jeffrey J.

“…A recent study suggested that the CHA2DS2-VASc score can risk stratify heart failure (HF) patients without atrial fibrillation (AF) for stroke. We performed a…”
Get full text

Hepatocellular Carcinoma to the Right Ventricle by Chaparro, Sandra V., Rodriguez, Alexis P., Badheka, Apurva, Marzouka, George R.

“…Hepatocellular carcinoma (HCC) is the sixth most prevalent cancer in the world, but metastatic disease to the heart is rare. We present a case of a 63-year-old…”
Get full text

Association between anti-human heat shock protein-60 and interleukin-2 with coronary artery calcium score by Damluji, Abdulla A, Ramireddy, Archana, Al-Damluji, Mohammed S, Marzouka, George R, Otalvaro, Lynda, Viles-Gonzalez, Juan F, Dong, Chunming, Alfonso, Carlos E, Hendel, Robert C, Cohen, Mauricio G, Moscucci, Mauro, Bishopric, Nanette H, Myerburg, Robert J

“…Based upon evidence suggesting that concentrations of anti-heat shock protein-60 (anti-HSP60) and interleukin-2 (IL-2) are associated with atherogenesis, we…”
Get more information

Dual ventricular rhythm by Badheka, Apurva O, Grover, Peeyush M, Tanawuttiwat, Tanyanan, Badiye, Amit, Marzouka, George R, Patel, Nileshkumar J, Chaparro, Sandra V, Mitrani, Raul D

Get more information

WARFARIN VERSUS ASPIRIN FOR PREVENTION OF STROKE IN HEART FAILURE: A META-ANALYSIS by Mehta, Kathan, Grover, Peeyush, Patel, Nileshkumar J, Shah, Neeraj, Singh, Vikas, Deshmukh, Abhishek, Marzouka, George R, Rathod, Ankit, Savani, Ghanshyam, Chothani, Ankit, Badheka, Apurva O, Cohen, Mauricio G

“…Conclusion Warfarin reduces the risk of stroke, but does not appear to decrease mortality or myocardial infarction in patients with HF when compared to aspirin…”
Get full text

OPTIMAL BLOOD PRESSURE IN PATIENTS WITH ATRIAL FIBRILLATION by Patel, Nileshkumar J, Shah, Neeraj, Grover, Peeyush, Singh, Vikas, Marzouka, George R, Parikh, Valay, Deshmukh, Abhishek, Rathod, Ankit, Badheka, Apurva O, Lafferty, James, Mehta, Jay L, Mitrani, Raul D

“…The secondary outcome was a composite of ACM, sustained ventricular tachycardia, ventricular fibrillation, pulseless electrical activity, clinically…”
Get full text

PREVALENCE OF VACCINATION IN SYSTOLIC HEART FAILURE: A PROSPECTIVE STUDY OF 549 PATIENTS BY RACE/ETHNICITY AND GENDER by Marzouka, George R, Julian, Elyse, Cortazar, Frank B, Dias, Andre, Tamariz, Leonardo, Hebert, Kathy

Get full text

Pseudo‐Pulmonic Stenosis in Non‐Hodgkin's Large B‐cell Lymphoma by Badheka, Apurva, Marzouka, George R., Patel, Nileshkumar J., Esterson, Joseph, Sequeira, Rafael F.

“…There have only been a few cases reported of right ventricular outflow tract obstruction secondary to diffuse large B‐cell lymphomas. Mediastinal masses rarely…”
Get full text

STROKE RISK IN HEART FAILURE AND ATRIAL FIBRILLATION - DOES EJECTION FRACTION MATTER? by Vaz, Igor, Tangri, Apoorva, Ceron, Carlos, Rivner, Harold, Singh, Harpreet, Marzouka, George R.

Get full text

Abstract 17248: Statin Therapy Increases Coronary Artery Calcification Scores by Rivner, Harold, Denis, Rimsky, Tang, Fei, Marzouka, George R

“…IntroductionCoronary artery calcification (CAC) assessment is a noninvasive test to determine atherosclerotic burden. There has been a discordance with the…”
Get full text

Abstract 17114: CHA 2 DS 2 -VASc Score is a Poor Predictor of Thromboembolic Events in Heart Failure Patients With and Without Atrial Fibrillation by Rivner, Harold, Marzouka, George R, Tang, Fei, Goldberger, Jeffrey J

“…Abstract only Introduction: Recent evidence suggests that the CHA 2 DS 2 -VASc score could be used to predict thromboembolic events (TE) (both CVA and…”
Get full text